Granules India Q4 Results: Profit Rises 8%, Misses Estimates
Net profit grew 8% to Rs 130 crore in the quarter ended March, compared with Rs 120 crore in the year-ago period.15-05-2024
Granules India Q4 Results: Profit Rises 8%, Misses Estimates
Net profit grew 8% to Rs 130 crore in the quarter ended March, compared with Rs 120 crore in the year-ago period.GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Audited Financial results for Q4 and financial year ended on March 31, 2024GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Audited Financial Results for Q4 and Financial year ended on March 31, 2024GRANULES INDIA LTD.-$ - 532482 - Outcome Of The Board Meeting
Outcome of the Board MeetingGRANULES INDIA LTD.-$ - 532482 - Audited Financial Results For Q4 And Financial Year Ended On March 31, 2024
Audited Financial Results for Q4 and Financial year ended on March 31, 2024GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Approval Of The Audited Financial Results For Q4 And Financial Year Ended On March 31, 2024.
Approval of the Audited Financial Results for Q4 and Financial Year ended on March 31, 2024.GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Earnings Conference call for Q4 and financial year ended on March 31, 2024.Granules India receives USFDA approval for Colchicine capsules
Colchicine capsules are indicated for prophylaxis of gout flares in adultsGRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Consideration And Approval For The Audited Financial Results For The Fourth Quarter And Financial Year Ended On March 31, 2024 And Final Dividend For FY24, If Any.
GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the audited financial results for the fourth quarter and financial year ended on March 31, 2024 and the final dividend for FY24, if any.